Loading PLTR…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("PLTR","financials")Full statements spill as a table. For one cell: =jivedata("PLTR","Revenue") or =jivedata("PLTR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
PLTR • CIK 0001321655
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenue from Contract with Customer, Excluding Assessed Tax | $2,225,012 | $2,865,507 | $4,475,446 | $6,155,941 |
| Cost of Revenue | $431,105 | $565,990 | $789,177 | $935,941 |
| Gross Profit | $1,793,907 | $2,299,517 | $3,686,269 | $5,220,000 |
| Operating Income (Loss) | $119,966 | $310,403 | $1,414,015 | $2,634,652 |
| Investment Income, Interest | $132,572 | $196,792 | $229,181 | $266,384 |
| Other Nonoperating Income (Expense) | $-11,977 | $-18,022 | $14,172 | $170,794 |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $237,091 | $489,173 | $1,657,368 | $3,071,830 |
| Income Tax Expense (Benefit) | $19,716 | $21,255 | $22,724 | $41,111 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $217,375 | $467,918 | $1,634,644 | $3,030,719 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $7,550 | $5,728 | $9,611 | $14,027 |
| Net Income (Loss) Attributable to Parent | $209,825 | $462,190 | $1,625,033 | $3,016,692 |
| Weighted Average Number of Shares Outstanding, Basic | 2,147,446,000 | 2,250,163,000 | 2,369,612,000 | 2,409,490,000 |
| Weighted Average Number of Shares Outstanding, Diluted | 2,297,927,000 | 2,450,818,000 | 2,565,197,000 | 2,577,112,000 |
| Selling and Marketing Expense | $744,992 | $887,755 | $1,056,859 | $1,235,482 |
| Research and Development Expense | $404,624 | $507,878 | $557,677 | $641,239 |
| General and Administrative Expense | $524,325 | $593,481 | $657,718 | $708,627 |
| Operating Expenses | $1,673,941 | $1,989,114 | $2,272,254 | $2,585,348 |
| Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | 150,481,000 | 200,655,000 | 195,585,000 | 167,622,000 |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 175,245,000 | 0 | — | -3,153,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | $831,047 | $2,098,524 | $1,423,796 | $2,030,047 |
| Marketable Securities, Current | $2,843,132 | $3,131,463 | $5,753,247 | $7,379,052 |
| Property, Plant and Equipment, Net | $47,758 | $39,638 | $51,960 | $61,403 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $364,784 | $575,048 | $1,042,065 | $1,485,249 |
| Operating Lease, Right-of-Use Asset | $182,863 | $200,740 | $200,105 | $230,268 |
| Prepaid Expense and Other Assets, Current | $99,655 | $129,254 | $139,066 | $205,165 |
| Other Assets, Noncurrent | $153,186 | $166,217 | $290,153 | $287,380 |
| Assets, Current | $4,138,618 | $5,934,289 | $8,358,174 | $11,099,513 |
| Assets | $4,522,425 | $6,340,884 | $8,900,392 | $11,678,564 |
| Deferred Revenue, Noncurrent | $28,047 | $39,885 | $46,216 | $33,722 |
| Operating Lease, Liability, Noncurrent | $175,216 | $195,226 | $183,474 | $211,400 |
| Other Liabilities, Noncurrent | $10,702 | $13,685 | $7,092 | $12,439 |
| Liabilities | $961,460 | $1,246,477 | $1,412,381 | $1,793,680 |
| Stockholders' Equity Attributable to Parent | $3,475,561 | $5,003,275 | $7,387,268 | $9,774,194 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $85,404 | $91,132 | $100,743 | $110,690 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $3,560,965 | $5,094,407 | $7,488,011 | $9,884,884 |
| Accounts Payable, Current | $12,122 | $103 | $8,064 | $3,102 |
| Accrued Liabilities, Current | $222,991 | $427,046 | $355,624 | $504,070 |
| Deferred Revenue, Current | $246,901 | $259,624 | $408,963 | $579,437 |
| Operating Lease, Liability, Current | $54,176 | $43,993 | $45,864 | $45,864 |
| Liabilities, Current | $746,018 | $996,018 | $1,175,581 | $1,535,582 |
| Common Stock, Value, Issued | $2,200 | $2,339 | $2,391 | $2,403 |
| Additional Paid in Capital | $9,122,173 | $10,193,970 | $10,933,325 | $11,408,867 |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $801 | $-5,611 | $13,942 | $-7,103 |
| Retained Earnings (Accumulated Deficit) | $-5,649,613 | $-5,187,423 | $-3,562,390 | $-1,629,973 |
| Common Stock, Shares Authorized | 22,701,005,000 | 22,701,005,000 | 22,701,005,000 | 22,701,005,000 |
| Common Stock, Shares, Issued | 2,200,128,000 | 2,338,795,000 | 2,391,192,000 | 2,402,897,000 |
| Property, Plant and Equipment, Gross | $149,916 | $162,637 | $201,051 | $201,051 |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $102,158 | $122,999 | $149,091 | $149,091 |
| Employee-related Liabilities, Current | $83,094 | $306,939 | $178,659 | $144,079 |
| Other Accrued Liabilities, Current | $92,640 | $77,864 | $176,965 | $252,104 |
| Operating Lease, Liability | $229,392 | $239,219 | $229,338 | $229,338 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $217,375 | $467,918 | $1,634,644 | $3,030,719 |
| Net Cash Provided by (Used in) Operating Activities | $712,183 | $1,153,865 | $2,134,473 | $3,400,291 |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $2,930 | $-6,745 | $7,477 | $-6,153 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-1,777,228 | $1,269,829 | $-668,511 | $1,112,124 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $850,107 | $2,119,936 | $1,451,425 | $2,761,279 |
| Depreciation, Depletion and Amortization | $33,354 | $31,587 | $26,145 | $27,978 |
| Payments to Acquire Property, Plant, and Equipment | $15,114 | $12,634 | $33,882 | $42,019 |
| Share-based Payment Arrangement, Noncash Expense | $475,903 | $691,638 | $684,033 | $835,524 |
| Payments to Acquire Marketable Securities | $5,636,406 | $5,395,913 | $7,702,060 | $8,631,128 |
| Debt and Equity Securities, Unrealized Gain (Loss) | $-13,160 | $-19,306 | $-21,228 | $40,562 |
| Proceeds from Sale and Maturity of Marketable Securities | $2,889,268 | $5,073,507 | $5,026,315 | $6,391,142 |
| Payments to Acquire Other Investments | $0 | — | $72,924 | $72,924 |
| Other Operating Activities, Cash Flow Statement | $-29,449 | $24,795 | $15,630 | $-96,485 |
| Payments for (Proceeds from) Other Investing Activities | $0 | $5,615 | $1,000 | $-69,000 |
| Net Cash Provided by (Used in) Investing Activities | $-2,711,180 | $-340,655 | $-2,783,551 | $-2,285,929 |
| Proceeds from Stock Options Exercised | $218,238 | $745,396 | $129,107 | $43,663 |
| Payments for Repurchase of Common Stock | — | $64,196 | $74,985 | $74,985 |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | $218,280 | $81,117 | $81,117 |
| Proceeds from (Payments for) Other Financing Activities | $601 | $444 | $85 | $-1,357 |
| Net Cash Provided by (Used in) Financing Activities | $218,839 | $463,364 | $-26,910 | $3,915 |
| Increase (Decrease) in Accounts Receivable | $106,159 | $211,157 | $450,429 | $720,729 |
| Increase (Decrease) in Prepaid Expense and Other Assets | $6,197 | $-7,202 | $-51,979 | $-5,380 |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | — | — | $4,659 | $44,554 |
| Increase (Decrease) in Contract with Customer, Liability | $64,347 | $54,440 | $238,688 | $374,550 |
| Increase (Decrease) in Other Operating Liabilities | — | — | $-54,860 | $-47,835 |